Correspondence 0001193125-23-044795 from VectivBio Holding AG (CIK 0001836379)
VectivBio Holding AG (CIK 0001836379)
Date: Feb. 22, 2023 · CIK: 0001836379 · Accession: 0001193125-23-044795
AI Filing Summary & Sentiment
File numbers found in text: 333-269450
Letter
February 22, 2023
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jason Drory
Re: VectivBio Holding AG
Registration Statement on Form F-3
Filed January 27, 2023
File No. 333-269450
Acceleration Request
Requested Date: February 24, 2023
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-269450) (the “Registration Statement”), to become effective on February 24, 2023, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the Commission’s staff. The Registrant hereby authorizes Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Brandon Fenn of Cooley LLP at (212) 479-6626.
[Signature page follows]
Very truly yours,
VectivBio Holding AG
Show Raw Text
CORRESP 1 filename1.htm CORRESP February 22, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Jason Drory Re: VectivBio Holding AG Registration Statement on Form F-3 Filed January 27, 2023 File No. 333-269450 Acceleration Request Requested Date: February 24, 2023 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-269450) (the “Registration Statement”), to become effective on February 24, 2023, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the Commission’s staff. The Registrant hereby authorizes Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Brandon Fenn of Cooley LLP at (212) 479-6626. [Signature page follows] Very truly yours, VectivBio Holding AG By: /s/ Luca Santarelli Luca Santarelli Chief Executive Officer cc: Scott Applebaum, VectivBio Holding AG Brandon Fenn, Cooley LLP Dayne Brown, Cooley LLP Andreas Müller, Homburger AG